Helaina
PrivateLast Round
Early Funding
Jun 2, 2026
Est. Valuation
$65M
Total Funding Raised
$74.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Helaina is a biotechnology company that produces human-equivalent bioactive proteins through precision fermentation for use in nutritional products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Smart Manufacturing
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Helaina Comparables
Compare Helaina with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TurtleTree | 91% | |
| De Novo Foodlabs | 85% | |
| All G Foods | 85% |
Helaina Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 2, 2026 | ||||
| Series B | Sep 25, 2024 | ||||
| Series A | Nov 19, 2021 | ||||
| Seed | Aug 31, 2020 |
Key People
Founding team and executive leadership
Helaina Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Siam Capital | Series A, Series B |
| Relish Works | Series B |
| Plum Alley Investments | Series A |
| Avidity Partners | Series B |
| Spark Capital | Series B, Series A |
| Barrel Ventures | Series B, Series A, Seed |
| Ingeborg Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Raised $12M in early funding.
- Mar 1, 2026
Effera™, an identical replica of human lactoferrin, has been launched.
Helaina Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Helaina's valuation, stock price, and market status.
Is Helaina a public or private company?
Helaina is a private company.
What is the current stock price of Helaina?
Helaina is a private company with no public stock price. No recent secondary market data is available.
How much is Helaina worth (valuation)?
Helaina's valuation is estimated at $65.0M based on funding round data.
Can I buy Helaina stock?
Helaina shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Helaina's last funding round?
Helaina's most recent funding round was Series B on November 19, 2021.
Who are the main investors in Helaina?
Key investors in Helaina include Siam Capital, Avidity Partners, Spark Capital.
Will Helaina IPO soon?
No public IPO plans have been announced for Helaina.
How can I track Helaina secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Helaina's secondary market activity and sign up for updates.